Neural Regeneration Research, 2023 · DOI: 10.4103/1673-5374.369118 · Published: March 3, 2023
This study investigates the role of EphA4 signaling in ferroptosis following spinal cord ischemia/reperfusion injury (SCIRI) in rats. SCIRI can lead to significant neurological dysfunction and motor neuron death. The researchers found that EphA4 expression increases after SCIRI, worsening ferroptosis-related indicators and motor nerve function. Inhibiting EphA4 largely rescued the detrimental effects of SCIRI. The study also identified that EphA4 interacts with proteins such as Beclin1 and Erk1/2, promoting Beclin1-XCT complex formation and activating the Erk1/2/c-Myc/transferrin receptor 1 axis. The conclusion is that EphA4 participates in regulating ferroptosis of spinal motor neurons in SCIRI by promoting the Beclin1-XCT complex and activating the Erk1/2/c-Myc/transferrin receptor 1 axis. This suggests EphA4 as a potential therapeutic target for SCIRI.
EphA4 is a potential therapeutic target for reducing neuronal ferroptosis after spinal cord ischemia/reperfusion injury.
Inhibiting EphA4 expression can improve neurological function and reduce neuroinflammation and BSCB leakage after SCIRI.
Future studies should investigate the mechanisms and signaling pathways that regulate cell death in SCIRI to develop better treatment strategies.